Free Trial

Lancashire (LRE) Competitors

Lancashire logo
GBX 617 +10.00 (+1.65%)
As of 09/12/2025 11:51 AM Eastern

LRE vs. MDC, ROAD, CCT, GEO, PRIM, EME, CCS, PHM, J, and MTH

Should you be buying Lancashire stock or one of its competitors? The main competitors of Lancashire include Mediclinic International (MDC), Roadside Real Estate (ROAD), The Character Group (CCT), Georgian Mining (GEO), Primorus Investments (PRIM), Empyrean Energy (EME), Crossword Cybersecurity (CCS), Phimedix Plc (PHM.L) (PHM), Jacobs Engineering Group (J), and Mithras Investment Trust (MTH). These companies are all part of the "construction" industry.

Lancashire vs. Its Competitors

Lancashire (LON:LRE) and Mediclinic International (LON:MDC) are both construction companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, Lancashire had 1 more articles in the media than Mediclinic International. MarketBeat recorded 1 mentions for Lancashire and 0 mentions for Mediclinic International. Lancashire's average media sentiment score of 0.00 equaled Mediclinic International'saverage media sentiment score.

Company Overall Sentiment
Lancashire Neutral
Mediclinic International Neutral

Lancashire currently has a consensus price target of GBX 690.25, indicating a potential upside of 11.87%. Given Lancashire's stronger consensus rating and higher possible upside, analysts plainly believe Lancashire is more favorable than Mediclinic International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lancashire
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Mediclinic International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Lancashire pays an annual dividend of GBX 0.24 per share and has a dividend yield of 0.0%. Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays out 25.9% of its earnings in the form of a dividend. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire is clearly the better dividend stock, given its higher yield and lower payout ratio.

Lancashire has a net margin of 37.12% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 10.76% beat Mediclinic International's return on equity.

Company Net Margins Return on Equity Return on Assets
Lancashire37.12% 10.76% 6.75%
Mediclinic International 4.99%5.50%2.30%

Lancashire has higher earnings, but lower revenue than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lancashire£1.82B0.82£199.02M£0.92670.65
Mediclinic International£3.38B0.00£169M£0.23N/A

63.4% of Lancashire shares are owned by institutional investors. Comparatively, 39.2% of Mediclinic International shares are owned by institutional investors. 4.6% of Lancashire shares are owned by insiders. Comparatively, 48.9% of Mediclinic International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Lancashire has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Mediclinic International has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500.

Summary

Lancashire beats Mediclinic International on 13 of the 16 factors compared between the two stocks.

Get Lancashire News Delivered to You Automatically

Sign up to receive the latest news and ratings for LRE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LRE vs. The Competition

MetricLancashireInsurance IndustryFinancial SectorLON Exchange
Market Cap£1.49B£2.63B£6.38B£2.58B
Dividend Yield3.05%2.27%4.31%5.30%
P/E Ratio670.65465.351,776.555,410.94
Price / Sales0.82169.391,344.7696,691.90
Price / Cash2.172.04127.4727.93
Price / Book1.011.672.067.77
Net Income£199.02M£474.99M£1.23B£5.89B
7 Day Performance4.22%1.40%7.06%6.51%
1 Month PerformanceN/A-1.78%7.50%55.94%
1 Year Performance-8.65%11.85%30.87%147.85%

Lancashire Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LRE
Lancashire
2.8688 of 5 stars
GBX 617
+1.6%
GBX 690.25
+11.9%
-7.6%£1.49B£1.82B670.65393
MDC
Mediclinic International
N/AN/AN/AN/A£3.69B£3.38B2,178.261,640
ROAD
Roadside Real Estate
N/AGBX 51.88
-3.0%
N/A+160.9%£74.53M£590K188.503,790Gap Down
CCT
The Character Group
N/AGBX 290.16
-5.2%
N/A+1.9%£52.39M£118.82M984.931,540Dividend Increase
GEO
Georgian Mining
N/AGBX 0.34
+4.6%
N/A-71.0%£15.71MN/A-395.3515,800Gap Down
PRIM
Primorus Investments
N/AGBX 4.30
+7.5%
N/A+21.0%£5.74M£3.25M223.6112,800
EME
Empyrean Energy
N/AGBX 0.06
-1.7%
N/A-80.1%£3.32MN/A-5.5835,500
CCS
Crossword Cybersecurity
N/AN/AN/AN/A£1.95M£4.19M-43.751,540Gap Down
High Trading Volume
PHM
Phimedix Plc (PHM.L)
N/AN/AN/AN/A£327KN/A-1.586,520Gap Down
High Trading Volume
J
Jacobs Engineering Group
N/AN/AGBX 250
+∞
N/A£0.00N/A0.0060,000High Trading Volume
MTH
Mithras Investment Trust
N/AN/AN/AN/A£0.00N/A0.001,920Gap Up

Related Companies and Tools


This page (LON:LRE) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners